8-K
filed June 1, 2026, 4:10 PM ET
ticker GPOR
CIK 0000874499
leadership
confidence high
sentiment neutral
materiality 0.60
Gulfport Energy appoints Domenic Dell'Osso to Board; CEO role effective May 28, 2026
GULFPORT ENERGY CORP
- Board increased to seven; Dell'Osso appointed director until 2027 Annual Meeting.
- Dell'Osso became CEO May 28; previously CEO of Expand Energy (EXE) until Feb 2026.
- Michael Sluiter, SVP Reservoir Engineering, receives $222,500 RSU grant with 1-year vest.
- Annual Meeting: all six director nominees elected; say-on-pay and auditor ratification approved.
- Dell'Osso receives no additional compensation for Board service.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-063506
- form_type
- 8-K
- ticker
- GPOR
- cik
- 0000874499
- company_name
- GULFPORT ENERGY CORP
- filed_at
- 2026-06-01T20:10:03+00:00
- discovered_at
- 2026-06-01T20:12:00.362718+00:00
- generated_at
- 2026-06-01T20:19:44.523202+00:00
- sec_items
- ["5.02", "5.07"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-063506
- json_url
- https://secwatch.observer/filing/0001213900-26-063506.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-063506.md
- text_url
- https://secwatch.observer/filing/0001213900-26-063506.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/874499/000121390026063506/0001213900-26-063506-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/874499/000121390026063506/ea0292798-8k_gulfport.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
30e279839f
Domenic J. Dell'Osso, Jr. was appointed as member of the Board at GULFPORT ENERGY CORP.
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
b1836e7ade
Domenic J. Dell'Osso, Jr. was appointed as President and Chief Executive Officer at GULFPORT ENERGY CORP.
On May 4, 2026, Mr. Dell’Osso was appointed President and Chief Executive Officer of the Company effective as of May 28, 2026.
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
43cb240b3efda84a7986fa4b337ff082c5d31b3e
GULFPORT ENERGY CORP shareholders approved Ratification of Grant Thornton LLP as independent auditors at the 2026-05-27 meeting.
Proposal 2: Auditors Ratification Proposal The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent auditors for the fiscal year ending December 31, 2026.
SEC 8-K Item 5.07
confidence 0.9
SEC evidence
5ec9a2d5ede0327b1554099f95cbb6617d4cdddc
GULFPORT ENERGY CORP shareholders approved Advisory vote on executive compensation at the 2026-05-27 meeting.
Proposal 3: Say-on-Pay Proposal The Company’s stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company’s named executive officers.
SEC 8-K Item 5.07
confidence 0.9
SEC evidence
b07036e51bb71216b0973e03384cec6f1888172a
GULFPORT ENERGY CORP shareholders approved Election of Directors Timothy Cutt, David Wolf, Jason Martinez, Jeannie Powers, David Reganato and Mary Shafer-Malicki at the 2026-05-27 meeting.
Proposal 1: Election of Directors Timothy Cutt, David Wolf, Jason Martinez, Jeannie Powers, David Reganato and Mary Shafer-Malicki were elected to serve as the Company’s directors until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.
SEC 8-K Item 5.07
confidence 0.9
SEC evidence
Comparable filings
MGNO
Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair
Magnolia Bancorp, Inc.
June 1, 2026, 2:15 PM ET
leadership
Items 5.02, 5.07, 7.01, 9.01
same fact type: executive_change, shareholder_vote
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
Filing page
SEC filing
BELFA
Bel Fuse names Kenneth Lai as SVP ITDS; annual meeting approves 2026 equity plan
BEL FUSE INC /NJ
May 28, 2026, 2:24 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
on May 22, 2026, the Company determined to name Kenneth Lai as Senior Vice President ITDS, effective late second quarter or early third quarter of 2026. In this role, Mr. Lai’s responsibilities expand to include the Company’s India and private label operations, in addition to China and other Asia locations. As a result of this change in responsibilities, Mr. Lai is no longer determined to be an “executive officer” or “officer” of the Company as defined in Rules 3b-7 and 16a-1(f) under the Securities Exchange Act of 1934, as amended, respectively.
Filing page
SEC filing
VIR
Vir Biotechnology director Saira Ramasastry resigns; board shrinks to 7; annual meeting elects directors
Vir Biotechnology, Inc.
May 28, 2026, 9:01 AM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Filing page
SEC filing
HNST
The Honest Company promotes Curtiss Bruce to Chief Financial & Operating Officer and announces annual meeting results
Honest Company, Inc.
May 27, 2026, 4:35 PM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
On May 20, 2026, the Board of Directors of The Honest Company, Inc. (the “Company”) approved the promotion of Curtiss Bruce to the position of Chief Financial & Operating Officer, effective May 21, 2026 (the “Effective Date”).
Filing page
SEC filing
ALNY
Alnylam elects Benjamin F. Cravatt to board; shareholders re-elect directors and approve say-on-pay
ALNYLAM PHARMACEUTICALS, INC.
May 27, 2026, 4:30 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
Effective as of June 1, 2026, the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company’s Board from ten to eleven and elected Benjamin F. Cravatt, Ph.D. to fill the newly created vacancy.
Filing page
SEC filing
CRVL
CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026
CORVEL CORP
June 1, 2026, 5:05 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
Filing page
SEC filing
TTD
The Trade Desk appoints Nate Olmstead as CFO effective July 9, 2026; interim CFO Davis resumes CAO role
Trade Desk, Inc.
June 1, 2026, 4:35 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.
Filing page
SEC filing
WST
West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair
WEST PHARMACEUTICAL SERVICES INC
June 1, 2026, 4:32 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Comparable filing
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.